Facebook Linkedin RSS Twitter Youtube
Home 2024

Allogeneic cell

Roche-Poseida Lead Allogeneic CAR-T Advances after Showing Promise in Multiple Myeloma
Cancer

Roche-Poseida Lead Allogeneic CAR-T Advances after Showing Promise in Multiple Myeloma

Cell Therapy Manufacturing: Time to Move Fast
Bioprocessing

Cell Therapy Manufacturing: Time to Move Fast

Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies
Artificial Intelligence

Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies

GenCure and UT San Antonio Sign Agreement for Cell Therapy Collaboration
Bioprocessing

GenCure and UT San Antonio Sign Agreement for Cell Therapy Collaboration

Cell Therapy Industry Looks for Ways to Sustain Growth
Bioprocessing

Cell Therapy Industry Looks for Ways to Sustain Growth

Forwarding Allogeneic Therapies
Bioprocessing

Forwarding Allogeneic Therapies

Gene Therapy for ART-SCID Shows “Amazing” Results in 10 Children
Genome Editing

Gene Therapy for ART-SCID Shows “Amazing” Results in 10 Children

Evaluating CAR T Cells: In Vitro Potency Assays for Production, Quality Control, Efficacy, and Safety
Sponsored

Evaluating CAR T Cells: In Vitro Potency Assays for Production, Quality Control, Efficacy, and Safety

Charles River Wins Regulatory Approval to Produce Allogeneic Cell Therapy Drug Products for European Distribution
Bioprocessing

Charles River Wins Regulatory Approval to Produce Allogeneic Cell Therapy Drug Products for European Distribution

Genentech, Adaptimmune Launch Up to $3B Cancer T Cell Therapy Collaboration
Cancer

Genentech, Adaptimmune Launch Up to $3B Cancer T Cell Therapy Collaboration

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.